MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 540544 clinical trials

Sort by:

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

Phase 2

Recruiting

Conditions: Diffuse Large B-Cell Lymphoma

Interventions: Drug: Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx)

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Fudan University

Target Recruit Count: 130

Registration Number: NCT07001540

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

AI-Powered Fall Risk Prediction in Nursing Care

Not yet recruiting

Conditions: Accidental Falls
Risk Assessment
Nursing Assessment
Machine Learning
Computer Vision

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Inonu University

Target Recruit Count: 150

Registration Number: NCT07000981

Locations: 🇹🇷
Turgut Özal Medical Center, Malatya, Battalgazi, Turkey

A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Azvudine tablets(FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Henan Genuine Biotech Co., Ltd.

Target Recruit Count: 15

Registration Number: NCT07002268

Locations: 🇨🇳
Beijing Jishuitan Hospital, Beijing, China

Impact of Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS) on the Respiratory Physiology in Patients With Prolonged Mechanical Ventilation

Recruiting

Conditions: PICS

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: National Taiwan University Hospital

Target Recruit Count: 40

Registration Number: NCT07002710

Locations: 🇨🇳
National Taiwan University Hospital, Taipei City, Taiwan

Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity

Completed

Conditions: Interleukin-6
Plaque Psoriasis
Disease Severity

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Tanta University

Target Recruit Count: 50

Registration Number: NCT07001904

Locations: 🇪🇬
Tanta University, Tanta, El-Gharbia, Egypt

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolically Healthy Obesity
Hyperuricemia

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Ningbo No. 1 Hospital

Target Recruit Count: 17040

Registration Number: NCT07001865

Locations: 🇨🇳
the First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China, 315000, Ningbo, Zhejiang Province 315000 Recruiting, Ningbo, China

Innovating Technology Solutions for Residents in Support Housing Communities w SUD Through Community-Engaged Research

Not Applicable

Not yet recruiting

Conditions: Housing Problems
Household Substance Abuse
Substance Use Disorders
Harm Reduction

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.

Target Recruit Count: 25

Registration Number: NCT07001020

Locations: 🇺🇸
Oregon Research Behavioral Intervention Strategies, Inc., Springfield, Oregon, United States

Pectoral Nerve Block and Serratus Posterior Superior Intercostal Plane Block in Breast Cancer Surgery

Not Applicable

Not yet recruiting

Conditions: Nerve Block

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-05

Lead Sponsor: Antalya Training and Research Hospital

Target Recruit Count: 110

Registration Number: NCT07001657

Locations: 🇹🇷
Antalya Training and Research Hospital, Antalya, Turkey

Vitalis Cardio Pilot

Not Applicable

Recruiting

Conditions: Cardiovascular Disease Risk Factor

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: Lucas Carr

Target Recruit Count: 128

Registration Number: NCT07001774

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Phase 2

Not yet recruiting

Conditions: Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Peritoneal Carcinomatosis

Interventions: Drug: Standard of Care Chemotherapy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Diagnostic Laparoscopy
Procedure: Magnetic Resonance Imaging
Procedure: Intraperitoneal Port Placement
Drug: Intraperitoneal Paclitaxel

First Posted Date: 2025-06-03

Last Posted Date: 2025-06-03

Lead Sponsor: ECOG-ACRIN Cancer Research Group

Target Recruit Count: 148

Registration Number: NCT07001748

Prev
1
56
57
58
59
60
100
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy